Pediatric endocrinology · testified for the side defending the laws
Van Meter, a retired-Navy pediatric endocrinologist, testifies that biological sex is binary and fixed at conception, that 'gender identity' and 'gender dysphoria' are psychological/sociological constructs rather than biologically-based conditions, and that there is no reliable evidence that transgender identity is innate. He argues that most gender-dysphoric children desist by late adolescence if not medically or socially affirmed, that puberty blockers and cross-sex hormones are unproven, irreversible-risk interventions amounting to experimentation on minors, and that WPATH and the major medical societies' guidelines reflect the views of an advocacy-driven minority rather than genuine scientific consensus. He consistently frames social, medical, and surgical transition of minors as harmful and unethical, and recommends in-depth mental-health evaluation and counseling aimed at aligning gender identity with natal sex instead. Several of his core paragraphs are repeated near-verbatim across declarations filed years apart in different cases.
Cases and documents
The documents are listed as the archive holds them. A document labeled with its kind alone, such as "Expert report", is one the archive attributes to the expert. One labeled "Mentions or contains" names the expert or includes the expert's testimony, and is not attributed to the expert.
Exhibit 128 - Memo Outlining Evidence for Change for Gender Identity Disorder in the DSM-5, 2013 Zucker, et al.
Exhibit 129 - A Developmental, Biopsychosocial Model for the Treatment of Children with Gender Identity Disorder, 2012 Zucker
Exhibit 130 - APA Statement on Zucker (2008)
Exhibit 131 - Working for Inclusion: Time for Congress to Enact Federal Legislation to Address Workplace Discrimination Against Lesbian, Gay, Bisexual, and Transgender Americans, Briefing Report
Exhibit 132 - Position Statement on Conversion Therapy, APA (Dec. 2018)
Exhibit 133 - Do Clinical Data from Transgender Adolescents Support the Phenomenon of Rapid Onset Gender Dysphoria, 2022 Bauer et al.
Exhibit 134 - American Society of Plastic Surgeons, State Focus on Gender Affirmation Intensifies, Feb. 25, 2021,
Exhibit 135 - Plastic surgeon: Sex-change operation utterly unacceptable and a form of child abuse, Sept. 9, 2019,
Exhibit 136 - Transphobic tweets linked to Oxford sociology professor, The Oxford Student (Oct. 26, 2018)
Exhibit 137 - Long-term outcomes of the treatment of central precocious puberty, 2016 Guaraldi, et al.
Exhibit 138 - Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty, 2021 Martinerie, et al.
Exhibit 140 - Gender Identity 5 Years After Social Transition, 2022 Olson et al.
Exhibit 141 - Puberty Suppression in Adolescents With Gender Identity Disorder, 2011 de Vries, et al.
Exhibit 142 - Understanding the Well-Being of LGBTQI+ Populations, 2020 Natl Academies of Sciences, Engineering, and Medicine
Exhibit 143 - The Health of Lesbian, Gay, Bisexual and Transgender People, 2011 Natl Academies of Sciences, Engineering, and Medicine
Exhibit 144 - The Right to the Best Care for Children Does Not Include the Right to Medical Transition, 2019 Laidlaw, et al.
Exhibit 145 - Strangers in a Strange Land, 2020 Donovan & Sotomayor
Exhibit 146 - Effect of antidepressant medications on semen parameters and male fertility, 2020 Beeder & Samplaski
Exhibit 147 - The effect of antidepressants on fertility, 2016 Casilla-Lennon, et al.
Exhibit 148 - Trends in Gender-affirming Surgery in Insured Patients in the U.S., 2018 Lane et al.
Exhibit 149 - Gender-Affirming Treatment of Gender Dysphoria in Youth, 2022 Clayton et al.
Exhibit 150 - AAP News, Risk of Pseudotumor Cerebri added to Labeling for Gonadotropin-Releasing Hormone Agonists, (2022)
Exhibit 151 - Longitudinal Impact of Gender-Affirming Endocrine Intervention on the Mental Health and Well-Being of Transgender Youths, 2020 Achille et al.
Exhibit 152 - Long-Term Effect of Gender-Affirming Hormone Treatment on Depression and Anxiety Symptoms in Transgender People, 2020 Aldridge et al.
Exhibit 153 - Off-Label Medication use in Children, More Common than We Think: A Systematic Review of the Literature, 2018 Allen et al.
Exhibit 154 - Association Between Gender-Affirming Surgeries and Mental Health Outcomes, 2021 Almazan et al.
Exhibit 155 - Top Surgery and Chest Dysphoria Among Transmasculine and Nonbinary Adolescents and Young Adults, 2022 Ascha et al.
Exhibit 156 - Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review, 2021 Baker et al.
Exhibit 157 - GRADE Guidelines: 3 Rating the Quality of Evidence, 2011 Balshem et al.
Exhibit 158 - Harry Benjamin, The Transsexual Phenomenon (1966)
Exhibit 159 - Anabolic Steroid Abuse and Dependence, 2002 Brower et al.
Exhibit 160 - Transgender and Gender-Nonbinary Patient Satisfaction after Transmasculine Chest Surgery, 2021 Bustos et al.
Exhibit 161 - Regret after Gender-affirmation Surgery: A Systematic Review and Metaanalysis of Prevalence, 2021 Bustos et al.
Exhibit 162 - Effects of Long-Term Exogenous Testosterone Administration on Ovarian Morphology, Determined by Transvaginal (3D) Ultrasound in Female-to-Male Transsexuals, 2017 Caanen et al.
Exhibit 163 - Short-term Outcomes of Pubertal Suppression in a Selected Cohort of 12 to 15 Year Old Young People with Persistent Gender Dysphoria in the UK, 2021 Carmichael at al.
Exhibit 164 - Psychosocial Functioning in Transgender Youth after 2 Years of Hormones, 2023 Chen et al.
Exhibit 165 - Pubertal Delay as an Aid in Diagnosis and Treatment of a Transsexual Adolescent, 1998 Cohen-Kettenis & van Goozen
Exhibit 166 - Hormonal Treatment Reduces Psychobiological Distress in Gender Identity Disorder, Independently of the Attachment Style, 2013 Colizzi et al.
Exhibit 167 - Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria, 2015 Costa et al.
Exhibit 168 - Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment, 2014 de Vries et al.
Exhibit 169 - An Analysis of All Applications for Sex Reassignment Surgery in Sweden, 1960-2010: Prevalence, Incidence, and Regrets, 2014 Dhejne et al.
Exhibit 170 - Gender Nonconforming Youth: Current Perspectives, 2017 Ehrensaft
Exhibit 171 - What makes clinical research ethical?, 2000 Emanuel et al.
Exhibit 172 - Treatment of Central Precocious Puberty, 2019 Eugster
Exhibit 173 - Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data, 2016 Fisher et al.
Exhibit 174 - Chest Surgery in Female to Male Transgender Individuals, 2017 Frederick et al.
Exhibit 175 - Off-Label Use of Drugs in Children, 2014 Galinkin et al.
Exhibit 176 - Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth, 2022 Green
Exhibit 178 - Satisfaction with Male-to-Female Gender Reassignment Surgery, 2014 Hess et al.
Exhibit 179 - Effects of Different Steps in Gender Reassignment Therapy on Psychopathology, 2014 Heylens, et al.
Exhibit 180 - Supporting Sexuality and Improving Sexual Function in Transgender Persons, 2019 Holmberg et al.
Exhibit 181 - Outcome of Vaginoplasty in Male-to-Female Transgenders: A Systematic Review of Surgical Techniques, 2015 Horbach et al.
Exhibit 182 - The Quality of Evidence for Medical Interventions Does Not Improve or Worsen: A Metaepidemiological Study of Cochrane Reviews, 2020 Howick et al.
Exhibit 183 - Testosterone Treatment and MMPI2 Improvement in Transgender Men, 2015 Keo-Meier et al.
Exhibit 184 - Bone Mass in Young Adulthood Following Gonadotropin-Releasing Hormone Analog Treatment and Cross-Sex Hormone Treatment in Adolescents with Gender Dysphoria, 2015 Klink et al.
Exhibit 185 - Fertility Options in Transgender and Gender Diverse Adolescents, 2017 Knudson & De Sutter
Exhibit 186 - Australian Children and Adolescents with Gender Dysphoria, 2021 Kozlowska et al.
Exhibit 187 - Body Dissatisfaction and Mental Health Outcomes of Youth on Gender-Affirming Hormone Therapy, 2020 Kuper et al.
Exhibit 188 - Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning, 2014 Light, et al.
Exhibit 189 - Psychosocial Assessment in Transgender Adolescents, 2020 Lopez de Lara.
Exhibit 190 - Christy Mallory et al., Conversion Therapy and LGBT Youth 2 (2019 ed.)
Exhibit 191 - Successful Oocyte Cryopreservation Using Letrozole as an Adjunct to Stimulation in a Transgender Adolescent after GnRH Agonist Suppression, 2021 Martin et al.
Exhibit 192 - Experience of Chest Dysphoria and Masculinizing Chest Surgery in Transmasculine Youth, 2021 Mehringer et al.
Exhibit 193 - Breast Augmentation in Male-to-Female Transgender Patients: Technical Considerations and Outcomes, 2019 Miller et al.
Exhibit 194 - Guiding the ConversationTypes of Regret after Gender-Affirming Surgery and Their Associated Etiologies, 2021 Narayan et al.
Exhibit 195 - Individual Treatment Progress Predicts Satisfaction with Transition-Related Care for Youth with Gender Dysphoria, 2021 Nieder et al.
Exhibit 196 - Sexual Experiences in Transgender People, 2018 Nikkelen & Baudewijntje.
Exhibit 197 - Quality of Life of Treatment-Seeking Transgender Adults, 2018 Nobili et al.
Exhibit 198 - Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults: Comparisons of Nonsurgical and Postsurgical Cohorts, 2018 Olson-Kennedy et al.
Exhibit 199 - Mental Health of Transgender Children Who Are Supported in Their Identities, 2016 Olson, et al.
Exhibit 200 - Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals, 2018 Owen-Smith, et al.
Exhibit 299 - (Redacted) Email communication between AHCA and Magellan regarding coverage of GnRH to treat gender dysphoria
Exhibit 300 - AHCA communication regarding the Special Services Criteria for puberty blockers 6/10/2022
Exhibit 301 - Communication between Jason Weida and Dr. Van Mol about a witness for the July 8th hearing 6/14/2022
Exhibit 302 - Email communication between Dr. Christopher Cogle and Jeffrey English 6/27/2022
Exhibit 303 - Communication regarding meeting between Miriam Grossman, Dr. Van Mol, Jason Weida, Andrew Sheeran, and Holtzman Vogel regarding July 8th hearing 6/30/2022
Exhibit 304 - Communication between Dr. Van Mol and AHCA - 7/2/2022
Exhibit 305 - Brief of the July 8th rule hearing 7/8/2022
Exhibit 306 - Transcript from July 8th rule hearing 7/8/2022
Exhibit 307 - Email from Miriam Grossman 7/10/2022
Exhibit 308 - Email communications with Jason Weida and Dr. Van Mol 7/14/2022
Exhibit 309 - Communications regarding AHCAs development of public comment binder provided to the consultants 7/19/2022
Exhibit 310 - Invoice from Dr. Van Meter 8/4/2022
Exhibit 311 - Communication to Jason Weida regarding witnesses for a hearing 8/10/2022
Deposition: DEPOSITION of Quentin Van Meter, M.D. taken on September 27, 2019 by Defendants Amy Acton, Chief, Office of Vital Statistics, State Registrar, Office of Vital Statistics. (Blake, Jason) Open↗(opens another site) · In the case's documents
Each ruling that discusses their testimony, by what it did for the side that called them. The counts are the profile's own, for the rulings it lists.
Helped the side that called them: 0Credited against the side that called them: 0Discounted, criticized or limited: 2Neither: 2
2020
A Texas family-court custody case (Harris County)
Discounted, criticized or limitedExcluded
Texas District Court, Harris County · motion to strike an expert · court order
Their role: Expert witness in a custody case; the order was later filed by the plaintiffs in Dekker v. Weida as an exhibit.
After a hearing, the court found him discredited as an expert on whether an adolescent transgender child should receive puberty blockers and whether affirming a child's gender is harmful, and struck him as an expert witness in the case.
“is discredited as an expert to give testimony in this cause on his opinions regarding the legal question of whether an adolescent transgender child should be administered puberty blockers”
United States Court of Appeals for the Fourth Circuit · appeal (merits, affirming summary judgment) · court opinion
Their role: Retained by defendant Gloucester County School Board; described by the court as an expert who disagrees with the WPATH Standards of Care and treats transgender youth by encouraging them to live in accordance with their sex assigned at birth.
The Fourth Circuit noted that aspects of Van Meter's report contradict the views of Grimm's expert, the American Academy of Pediatrics, and the court's other medical amici, but held that the School Board relied on his testimony only for the narrow assertion that Grimm remained biologically female. The court found his report did not create a genuine factual dispute affecting its legal analysis and declined to consider the remainder of his assertions.
“That did not prevent the Board from finding an expert, Dr. Quentin Van Meter, who disagrees with the WPATH Standards of Care, and who treats transgender youth by encouraging them to live in accordance with their sex assigned at birth.”
“Aspects of Dr. Van Meter’s report blatantly contradict the views of Grimm’s expert, as well as the American Academy of Pediatrics and our other medical amici.”
United States District Court for the Eastern District of Tennessee · motion to dismiss (standing/ripeness) · court opinion
Their role: Not a witness in this case: president of the plaintiff organization, the American College of Pediatricians.
The court's background section recites, as an allegation from the complaint, that ACPeds's president Dr. Van Meter averred the organization is secular but has "deep, substantial, science-based concerns about transgender interventions." The court granted the government's motion to dismiss for lack of standing and ripeness; this ruling did not turn on any assessment of Van Meter's statement, which is treated as an unadjudicated pleading allegation.
“President of ACPeds, Dr. Quentin Van Meter, averred that the organization has some religious members, but it is a secular organization that has “deep, substantial, science-based concerns about transgender interventions”
American College of Pediatricians v. Becerra: MEMORANDUM OPINION: the Court GRANTS Defendants' motion to dismiss (Doc. 52 ).
Source: American College of Pediatricians v. Becerra: MEMORANDUM OPINION: the Court GRANTS Defendants' motion to dismiss (Doc. 52 ).
2023
Eknes-Tucker v. Governor of the State of Alabama (formerly Boe v. Marshall)
NeitherDescribed, not weighed
United States Court of Appeals for the Eleventh Circuit · appeal (vacating preliminary injunction) · court opinion
Their role: Retained by defendant State of Alabama; described by the court as "a board-certified pediatrician and pediatric endocrinologist who currently works in private practice," who submitted a declaration comparing puberty blockers for precocious puberty to puberty blockers for gender dysphoria.
In the factual-background section of its opinion vacating the district court's preliminary injunction, the Eleventh Circuit recites that Alabama produced a declaration from Van Meter comparing the use of puberty blockers for precocious puberty to their use for gender dysphoria as "comparing apples to oranges," citing lack of long-term safety data. The court does not separately assess or weigh his opinion; its ultimate holding (vacating the injunction) turns on due-process and equal-protection analysis, not an evaluation of this declaration's credibility.
“Dr. Van Meter is a board-certified pediatrician and pediatric endocrinologist who currently works in private practice.”
Not in the archive: The Eleventh Circuit's Eknes-Tucker opinion references 'Opening Br. 12, 27, 46' regarding how the Board's opening brief characterized Van Meter's testimony in the related Grimm case -- that brief is not among these files. The Eknes-Tucker/Boe v. Marshall district court's own findings on the weight or credibility of Van Meter's declaration (the district court order granting the preliminary injunction, referenced at 112849 lines ~679-693 as having been 'based on... a determination that Plaintiffs had shown a substantial likelihood of success') are not included in this file set -- only the appellate recitation of what was submitted below is available here.
Cases and roles
Case
Years
Arena
Retained by
What they filed
Dekker v. Weida
U.S. District Court, N.D. Florida, Tallahassee Division (No. 4:22-cv-00325-RH-MAF)
2023
insurance-Medicaid
Defendants (Florida Agency for Health Care Administration, Secretary Jason Weida)
not established (docs reviewed show a declaration captioned in the Middle District of Alabama, No. 2:22-cv-00184-LCB-CWB, Rev. Paul A. Eknes-Tucker v. Kay Ivey; other Boe-labeled docs are 11th Circuit appendix/exhibit items with no captured full text)
Also named in these cases' filings, though the archive holds no testimony of their attributed to them: DOE v. LADAPO.
Typical stance
Sex is binary; DSD is not a third sex
He argues that biological sex is binary and determined at conception by chromosomal complement, that disorders of sex development (DSD) are rare, medically identifiable exceptions rather than a third sex, and that DSD patients are not the same as transgender people.
“The presence of a Y chromosome in the developing fetus directs the developing gonadal tissue to develop as a testicle.”
Seen in: Boe v. Marshall, Carcaño v. McCrory, Dekker v. Weida
Gender identity is a psychological/sociological construct, not biologically hard-wired
He argues 'gender' and 'gender identity' are terms coined by sexologists (notably John Money) and are not biological categories; twin studies and brain-imaging studies, in his reading, show no reliable biological basis for cross-sex identification.
““Gender” is a term that refers to the psychological and cultural characteristics associated with biological sex. It is a psychological concept and sociological term, not a biological one.”
Seen in: Carcaño v. McCrory, Boe v. Marshall, Dekker v. Weida
Most gender-dysphoric youth desist by late adolescence
He asserts that the large majority of pre-pubertal children with gender dysphoria will come to identify with their natal sex by late adolescence, and that counseling aimed at resolving (not affirming) the dysphoria is the ethical course.
“The light at the end of the tunnel is the proven scientific evidence that 80%- 95% of pre-pubertal children with GD will come to identify with their biological sex by late adolescence.”
“There are over 11 published studies which clearly prove that desistance occurs in children who have been allowed to proceed uninterrupted through natural puberty ranging 50-98 percent of the time.”
Seen in: Boe v. Marshall, Carcaño v. McCrory, Dekker v. Weida
Puberty blockers and cross-sex hormones are unproven, harmful interventions
He characterizes puberty suppression and cross-sex hormone therapy in gender-dysphoric minors as lacking safety/efficacy data, causing irreversible harms (bone density loss, infertility), and amounting to uncontrolled experimentation on children.
“using the puberty blockers for interrupting normal puberty is not a sanctionable off-label use of these drugs and is therefore to be considered uncontrolled, non-consentable experimentation on children.”
“Stopping puberty in the adolescent age range and then overlapping cross-sex hormones in supraphysiologic dosing is a completely different circumstance.”
Seen in: Boe v. Marshall, Carcaño v. McCrory, Dekker v. Weida
WPATH and affirming-care guidelines are advocacy, not consensus science
He argues WPATH is an advocacy organization without training requirements whose guidelines were written mainly by like-minded members and imposed on other medical societies without genuine membership consensus, so they do not constitute real 'standards of care.'
“WPATH is an agenda-driven advocacy organization whose membership consists of anyone who has an interest in the transgender social and political agenda. There are no requirements for specialty training or certification.”
Seen in: Carcaño v. McCrory, Boe v. Marshall, Dekker v. Weida
Social contagion / peer and online influence drives presentation
He attributes much of the rise in adolescent-onset gender dysphoria, especially among girls, to peer and social-media influence rather than an innate condition, citing Lisa Littman's rapid-onset gender dysphoria concept.
“In my experience, patients were convinced they had gender dysphoria because of the online influence to which they were exposed.”
Counseling toward natal-sex alignment is not 'conversion therapy'
In deposition he distinguishes what he calls counseling to resolve gender dysphoria from 'conversion therapy,' though his answers about how the two relate to each other and to gender-affirming care shift within the same deposition.
Seen in: Ray v. Director, Ohio Department of Health
Gender dysphoria reflects underlying, pre-existing mental health issues
He argues that patients referred to him with gender dysphoria typically have pre-existing depression or anxiety that preceded the dysphoria, and that this underlying morbidity, not an innate cross-sex identity, should be the treatment target.
“Patients referred to me with the diagnosis of gender dysphoria have undercurrent depression and/or anxiety that historically preceded the gender dysphoria.”
John Money's legacy discredits the theoretical basis of affirming care
He traces contemporary gender-affirming theory to John Money's discredited mid-20th-century experiments on intersex infants, arguing the field never corrected course from that flawed, unreviewed research program.
“Money experimented with DSD infants by assigning them to the opposite biological sex through surgical revision, counseling, and hormonal manipulation during puberty.”
“The legacy of John Money fell into disrepute and the transsexual treatment program at Johns Hopkin was closed in the 1980s based on the lack of evidence that this protocol produced an effective cure.”
His core factual/scientific paragraphs on fetal sex differentiation, DSD, John Money's history, twin studies, and neuroplasticity are essentially unchanged word-for-word from the 2016 Carcaño v. McCrory declaration (110945) through the 2022 Boe v. Marshall declaration (102407) -- see reused_text below. By the 2023 Dekker v. Weida rebuttal report (111964/112125), the format shifts from a freestanding declaration to a paragraph-by-paragraph rebuttal of a named opposing expert (Dr. Olson-Kennedy), and he adds new argument lines not present in the earlier declarations: attacking WPATH's SOC8 for dropping age criteria, citing the NIH-funded Chen et al. 2023 puberty-suppression study and foreign (UK/Sweden/Finland) restrictions on youth gender medicine, and emphasizing 'lack of transparency' at U.S. gender clinics and social-media-driven 'rapid-onset gender dysphoria.' In the 2020 Ray v. Director, Ohio deposition (104881), under oath he acknowledges he has not conducted or published original research on gender dysphoria or transgender people specifically (his CV publications are pediatric growth-hormone and general endocrinology studies plus letters/opinion pieces on transgender treatment), and that he did not testify on transgender issues in litigation until 2017 -- narrower claims than the confident 'consensus' framing of his written declarations.
Under cross-examination
Their own answers in depositions.
His own research on gender dysphoria · Ray v. Director, Ohio Department of Health
Question (paraphrased): Asked whether he has done scientific research related to gender dysphoria (Ray deposition, p. 132)
Gender incongruence as “a delusional state” · Ray v. Director, Ohio Department of Health
Question (paraphrased): After saying Kenneth Zucker “believed and stated that gender identity and gender incongruence is a delusional state,” asked whether he agrees; he went on to distinguish this from a clinical delusional disorder
Sentences that appear word for word in their filings in different cases.
“DSD patients are not “transgender”; they have an objective, physical, medically verifiable, physiologic condition. Transgender people generally do not have intersex conditions or any other verifiable physical anomaly.” in 2 documents: 102407, 110945
“Money experimented with DSD infants by assigning them to the opposite biological sex through surgical revision, counseling, and hormonal manipulation during puberty. His mode of operation was to have a theory and then experiment with patients to see how his theory worked.” in 2 documents: 102407, 110945
“Neuroplasticity is the well-established phenomenon in which long-term behavior alters brain microstructure.” in 2 documents: 102407, 110945
“Instead, 80 percent of identical twin pairs were discordant.” in 2 documents: 102407, 110945
“The use of cross-sex hormones can cause permanent infertility.” in 2 documents: 102407, 110945
“Sex reassignment surgery is, by nature, permanent.” in 2 documents: 102407, 110945
Curriculum vitae
Current positions
President of Van Meter Pediatric Endocrinology, P.C., a private pediatric endocrinology practice in Atlanta, Georgia. source
“I am currently a pediatric endocrinologist in private practice in
Atlanta, Georgia. I am the President of Van Meter Pediatric Endocrinology, P.C.”
Adjunct Associate Professor of Pediatrics on the clinical faculties of Emory University School of Medicine and Morehouse College of Medicine. source
“I am on the clinical faculties of Emory
University School of Medicine and Morehouse College of Medicine, in the role of adjunct
Associate Professor of Pediatrics.”
President of the American College of Pediatricians (an advocacy fellowship distinct from the mainstream American Academy of Pediatrics), per his own 2022 CV. source
“Fellow:
The American College of Pediatricians, 2007 – present
Member of the Board of Directors, 2008- present
President, 2018-present”
Education and training
B.A. in Science, College of William and Mary (1969); M.D., Medical College of Virginia, Virginia Commonwealth University (1973). source
“I received my B.A. in Science at the College of William and Mary, and my M.D. from
the Medical College of Virginia, Virginia Commonwealth University.”
Pediatric internship and residency at Naval Regional Medical Center, Oakland (per own deposition testimony, 1973-1976), then a pediatric endocrinology fellowship at Johns Hopkins Hospital (1978-1980). source
“And that was at Oakland Naval
22· ·Hospital, internship and residency in
23· ·pediatrics.· And then my fellowship at Johns
24· ·Hopkins in pediatric endocrinology from 1978 to
25· ·1980.”
Pediatric endocrinology fellowship, Johns Hopkins Hospital, 1978-1980, under fellowship program director Claude Migeon, M.D.; describes exposure there to Gender Identity Disorder patients and training under John Money, Ph.D. source
“I did my
Pediatric Endocrine fellowship at Johns Hopkins Hospital
from 1978-1980. The faculty present at that time had carried on the tradition of
excellence established by Lawson Wilkins, M.D.”
Past positions and roles
Twenty years of active-duty U.S. Navy service (Medical Corps, commissioned August 1971, retired as Captain), stated in his own deposition testimony. source
“I was in the Navy for 20 years.
19· ·During which time I was affiliated with
20· ·academic institutions and the Navy Medical
21· ·Corp.”
After Navy retirement, entered private practice while keeping adjunct academic/clinical teaching positions at Emory University and Morehouse College of Medicine (own deposition testimony). source
“Upon retirement, after a 20-year career
22· ·in the Navy, I went into private practice but
23· ·maintained academic and clinical teaching
24· ·positions, adjunct positions, at Emory
25· ·University and Morehouse College of Medicine.”
Chairman and Director of Residency Training, Department of Pediatrics, Naval Hospital Oakland, 1986-1991 (per own CV exhibit). source
“Chairman and Director, Residency Training, Department of Pediatrics
Naval Hospital Oakland, 1986 – 1991”
Prior faculty appointments: Assistant Clinical Professor of Pediatrics, UC San Diego School of Medicine (1980-1986); Associate Clinical Professor, UCSF (1989-1991); Clinical Instructor, LSU School of Medicine (1977-1978). source
“University of California, San Diego, School of Medicine
Position:
Assistant Clinical Professor, Pediatrics, 1980 – 1986”
Pediatric endocrinology consultant to several other military/regional hospitals in the 1980s-90s (Nellis AFB Hospital, Naval Hospital Lemoore, Letterman Army Medical Center). source
“Consultant, Pediatric Endocrinology,
Nellis Air Force Base Hospital, Las Vegas, Nevada
1981 – 1991”
Clinical practice
Currently practices as a pediatric endocrinologist in private practice in Atlanta, Georgia, as President of his own practice, Van Meter Pediatric Endocrinology, P.C. source
“I am currently a pediatric endocrinologist in private practice in
Atlanta, Georgia. I am the President of Van Meter Pediatric Endocrinology, P.C.”
Earlier private practice: partner, Pediatrician and Pediatric Endocrinologist, Fayette Medical Clinic, Peachtree City, Georgia, September 1991-October 2003 (per own CV exhibit). source
“Pediatrician and Pediatric Endocrinologist, partner
Fayette Medical Clinic
Peachtree City, Georgia 30269
September 1991 – October 2003”
Has worked as a paid pediatric endocrinologist peer reviewer since 2006 for two disability/insurance case-review firms, MCMC LLC (Boston) and IMEDECS (Lansdale, PA). source
Co-author, randomized clinical trial of recombinant IGF-1 in short children with low IGF-1 levels, J Clin Endocrinol Metab 2010 (his one cited clinical-trial publication, unrelated to gender medicine). source
“Midyett LK, Rogol AD, Van Meter QL, Frane J, and Bright GM,
“Recombinant Insulin-Like Growth factor (IGF)-I Treatment in Short
Children with Low IGF-I Levels: First-Year Results from a Randomized
Clinical Trial,” J Clin Endocrinol Metab, 2010;95:611–619.”
Co-signed a 2019 Letter to the Editor in J Clin Endocrinol Metab critiquing the Endocrine Society's Clinical Practice Guideline on gender-dysphoric/gender-incongruent persons. source
“Laidlaw MK, Van Meter QL, Hruz PW, Von Mol A, and Malone WJ,
Letter to the Editor: “Endocrine Treatment of Gender-Dysphoric/Gender-
Incongruent Persons: An Endocrine Society Clinical Practice Guideline,”
J CLin Endo Metab 2019;104: 1-2.”
Sole-authored opinion piece, "Bringing Transparency to the Treatment of Transgender Persons," Issues in Law and Medicine, 2019 (an advocacy-journal piece, not a peer-reviewed clinical study). source
“Van Meter QL, Bringing Transparency to the Treatment of Transgender
Persons, Issues in Law and Medicine 2019:34;147-152.”
Co-signed a second Letter to the Editor in J Clin Endocrinol Metab (2021) on erythrocytosis in transgender men using testosterone. source
“Laidlaw, MK Von Mol A,Van Meter Q, and Hansen JE, Letter to the
Editor from Laidlaw et al: “erythrocytoisis in a large cohort of
thansgender Men using testosterone: a long-term follow-up study on
prevalence, determinants, and exposure years” J Clin Endocrinol Metab,
2021 December 2021, e5275-35276”
Licenses, boards, honors
Board certified in Pediatrics and Pediatric Endocrinology; medical license held in Georgia since 1991, previously licensed in California, Louisiana, and Maryland (per his own declarations). source
“I am board certified in Pediatrics and Pediatric Endocrinology. I have been licensed to
practice medicine in Georgia since 1991. I have been previously licensed to practice medicine in
California, Louisiana, and Maryland.”
Diplomate, American Board of Pediatrics (general pediatrics, 1978); sub-board certified in Pediatric Endocrinology, 1983. source
“American Board of Pediatrics, certified in general pediatrics, 1978, sub-board certified
in Pediatric Endocrinology, 1983”
Fellow of the American College of Pediatricians since 2007; on its Board of Directors since 2008; became its President in 2018 (his own updated 2022 CV). source
“Fellow:
The American College of Pediatricians, 2007 – present
Member of the Board of Directors, 2008- present
President, 2018-present”
Fellow of the American Academy of Pediatrics 1975-2014, formerly President of its Uniformed Services West Chapter (1987-1990); Georgia medical license #34734. source
“Fellow:
American Academy of Pediatrics, 1975 -2014
President, Uniformed Services West Chapter, 1987 – 1990”
Disclosed compensation
Carcaño v. McCrory: $250/hour, all time devoted source
Paul Eknes-Tucker v. Governor of the State of Alabama (declaration filed as Rev. Paul A. Eknes-Tucker v. Kay Ivey, 2:22-cv-00184, and grouped under Boe v. Marshall in this corpus): $350/hour for record review and document preparation; $450/hour for deposition or court testimony source
Dekker v. Weida: $350/hour flat, inclusive of report drafting, travel, testimony, and consultation source
Ray v. Director, Ohio Department of Health: $1,500 retainer; $350/hour records review; $450/hour deposition ($3,500 that day, per his testimony, when out of state) source
Testimony they lists themselves
Gavin Grimm v. Gloucester Co. Virginia School Board 2019 · deposition
A family-court custody case, Harris County, Texas 2020 · deposition/trial
Dekker v. Weida (own deposition; answering counsel's question about when he first provided expert testimony on transgender issues, i.e. 2017) 2023 · deposition
and 5 other matters they lists that are not in the litigation archive.
What the parties argued about them
Party filings, not rulings: motions, briefs and proposed findings.
Boe v. Marshall (2022): This is Plaintiffs' reply brief in support of their motion for a TRO/preliminary injunction, not a court ruling. Plaintiffs argue that Van Meter's declaration attacking WPATH, Endocrine Society, American Academy of Pediatrics, and Pediatric Endocrine Society guidelines is an unsubstantiated claim "that read[s] like conspiracy theories," quoting his statement that those guidelines are the opinions of "like-minded practitioners." No court assessment of the declaration appears in this document. filing
Sources and method
Built from the litigation archive: 3 excerpts of opinions and oral arguments and 10 court documents that name them, and 13 filings of their own. Every mention was checked for identity (3 mentions of other people with the same surname were set aside). Every quote on this page (62) was checked word for word against its source. Profile version 1. Gaps: Case-attribution risk (flag before reuse): the two full-text documents this corpus assigned to 'Boe v. Marshall' (102407/107584) are themselves captioned as a declaration in 'Eknes-Tucker v. Ivey,' No. 2:22-cv-00184-LCB-CWB (M.D. Ala.) -- the exact same case number and parties as the separately-listed payload case 'Paul Eknes-Tucker v. Governor of the State of Alabama.' Boe v. Marshall is likely the 11th Circuit appeal of that same district-court case (renamed for a different named defendant-appellant), which would mean the corpus's '6 cases' figure double-counts one litigation across two case-name buckets; this was not independently verified and should be checked against PACER/CourtListener docket history before being treated as fact. Other gaps: (1) (DOE v. LADAPO) and all 13 volumes of the Eknes-Tucker expert report (112897-112909) had no extractable full text, so his court, retention, and specific opinions in those matters are not established here. (2) Whether the Dekker v. Weida court granted or denied plaintiffs' motion in limine to exclude/limit his testimony (-112113) is not established -- only the motion and memorandum were available, not a ruling. (3) The Harris County, Texas order striking him as an expert (a family-court custody case in Harris County, Texas, a family-law custody case, used as an impeachment exhibit in Dekker) is not one of the six litigation-database cases and is not itself a transgender-rights case; it is included only because it appears in this expert's own document set. (4) The deposition transcript for Ray v. Director, Ohio Department of Health is ~500,000 characters and may be truncated at a corpus-wide per-document text cap, so later portions were not reviewed and could contain additional relevant testimony. (5) His CV lists extensive pre-2016 clinical/academic history (full publication list, additional presentations, professional society roles) beyond what is summarized here; only the entries most relevant to his qualifications and litigation roles were pulled. (6) Per the brief's rules, his home address, date of birth, and place of birth (all present on the CV exhibits) were deliberately excluded from this file.